A Systematic Assessment of Drug Repurposing Efforts Against COVID‐19: Limited Successes and Key Challenges

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Systematic evaluation reveals limited success and challenges in drug repurposing for COVID-19 treatment.

None of the repurposed drugs were recommended by treatment guidelines, highlighting the limitations encountered.
Positive results were observed in 12 randomized clinical trials, but most had low participant numbers with minor clinical relevance.
The systematic analysis included 100 frequently prescribed drugs, identifying 33 with evidence of anti-COVID-19 effects.
Challenges like insufficient funding for late-stage trials hindered the potential benefits of drug repurposing efforts.

Riedel et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark